Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

This study has been terminated.

( Safety concerns )

Study NCT00040144 Information provided by Achillion Pharmaceuticals

First Received: June 21, 2002 Last Updated: August 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2003
Estimated Primary Completion Date:	No date given